SCHEMBL7778100

SCHEMBL7778100

CC=Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(C)cc2)c1COCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.44
PTGS1 P23219 6/20 0.44
CYP2C9 P11712 1/20 0.40
CA12 O43570 6/20 0.40
CA9 Q16790 6/20 0.40
CA2 P00918 3/20 0.40
CA1 P00915 2/20 0.40
CA4 P22748 2/20 0.40
CA5A P35218 2/20 0.40
CA7 P43166 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
AR P10275 1/20 0.40
MT-CO2 P00403 1/20 0.40
LMNA P02545 1/20 0.40
CA3 P07451 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779401 0.92 PTGS2 (0.54) PTGS2PTGS1CA12CA9CA2
SCHEMBL7773108 0.91 PTGS2 (0.45) PTGS2PTGS1AR
SCHEMBL8633055 0.87 AR (0.39) PTGS2PTGS1AR
SCHEMBL7780760 0.84 PTGS2 (0.47) PTGS2PTGS1
SCHEMBL7779966 0.83 PTGS2 (0.48) PTGS2PTGS1CYP2C9CA12CA9
SCHEMBL7779927 0.83 PTGS2 (0.48) PTGS2PTGS1CYP2C9CA12CA9
SCHEMBL7801339 0.83 PTGS2 (0.44) PTGS2PTGS1AR
SCHEMBL7778098 0.82 PTGS2 (0.43) PTGS2PTGS1CYP2C9CA12CA9
SCHEMBL7779800 0.82 PTGS2 (0.46) PTGS2PTGS1CYP2C9CA12CA9
SCHEMBL7779817 0.82 CA9 (0.48) PTGS2PTGS1CA12CA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed